AbbVie has never been shy about guarding its patents and hiking drug prices. Congress tore into the company this week. But will it lead to any real policy change? Read More
Related Articles
To go back or not to go back? That is the question for office-dwellers
As some companies embrace a move back to new HQ, others are navigating whether that’s really necessary for their workforce. Read More
Qualcomm’s outgoing CEO is the ultimate tech survivor
This is the web version of Data Sheet, a daily newsletter on the business of tech. Sign up to get it delivered free to your inbox. Qualcomm CEO Steve Mollenkopf must have been born with a bullseye on his back. During his seven-year tenure, activist hedge fund JANA Partners demanded that he break up the company; […]
Meet with the 3 Individuals Which will Establish economic policy for Another four Decades
President-elect Joe Biden cinched his position at the Oval Office and background early Saturday morning having a definitive triumph in Pennsylvania. Instantly, Americans in towns throughout the nation took to the roads, joyous in party. However although the Biden effort took a while to enjoy their extended and hard-fought win, but they are also prepared […]